Overview

A Study of EDP-297 in Healthy Subjects

Status:
Completed

Trial end date:
2021-06-21

Target enrollment:

Participant gender:

Summary

This study is a randomized, double-blind, placebo-controlled study. It will assess the safety, tolerability, and pharmacokinetics of orally administered single and multiple doses of EDP-297 in healthy adult subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Enanta Pharmaceuticals

Collaborator:

PRA Health Sciences